Close Menu

NEW YORK (GenomeWeb) – Agendia announced this week that it has created a Center of Innovation and R&D Excellence in the Netherlands. Through the new center, Agendia will leverage the expertise of its scientists, as well as researchers and collaborators in Europe, to advance next-generation sequencing technology in the diagnostics space. One focus of the new center will be to support products related to the firm's NGS offerings for its customers in Europe and Asia using Agendia's decentralized proprietary tests, including MammaPrint and BluePrint.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.